3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Metformin
6
Pioglitazone
2
Exercise
2
ziprasidone
1
salicylsalicylic acid
1
licogliflozin
1
exendin (9-39)
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
cinnulin PF
1
Vitamin D
1
Sugars
1
Sodium Salicylate
1
Resistance Training
1
Olanzapine
1
Leuprolide
1
Flutamide
1
Ethinyl Estradiol
1
Estrogens
1
Diet Therapy
1
Continuous Positive Airway Pressure
1
Cholecalciferol
1
Caloric Restriction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Insulin Resistance
×
licogliflozin
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts